Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis - PubMed (original) (raw)
Recombinant varicella-zoster virus glycoproteins E and I: immunologic responses and clearance of virus in a guinea pig model of chronic uveitis
H Kimura et al. J Infect Dis. 1998 Aug.
Abstract
Guinea pigs immunized with recombinant varicella-zoster virus (VZV) glycoproteins E (gE) and I (gI) developed antigen-specific antibodies in the sera, vitreous, and conjunctival washes. Sera from immunized animals neutralized both cell-free and cell-associated VZV, and peripheral blood lymphocytes proliferated in vitro in response to recombinant gE and gI and to antigens from VZV-infected cells. Immunized guinea pigs were inoculated intravitreally with VZV, which induces chronic uveitis. VZV DNA was more rapidly cleared and infectious VZV was isolated less frequently from the retinas of animals immunized with gE and gI compared with that in controls receiving adjuvant alone. Nonetheless, cellular infiltrates in the vitreous, retina, and choroid were prevalent 21 days after VZV inoculation in both the adjuvant-alone- and gE-gI-immunized animals. Immunization with VZV gE and gI induced potent humoral and cellular responses that accelerated the clearance of VZV DNA and may neutralize virus within the eye.
Similar articles
- Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ, Park HJ, Ko HL, Lee JE, Lee HJ, Kim H, Nam JH. Lee SJ, et al. Immun Inflamm Dis. 2020 Jun;8(2):216-227. doi: 10.1002/iid3.297. Epub 2020 Mar 13. Immun Inflamm Dis. 2020. PMID: 32167678 Free PMC article. - Immunogenicity of a recombinant varicella-zoster virus gE-IE63 fusion protein, a putative vaccine candidate against primary infection and zoster reactivation.
Jacquet A, Haumont M, Massaer M, Garcia L, Mazzu P, Daminet V, Grégoire D, Jacobs P, Bollen A. Jacquet A, et al. Vaccine. 2002 Feb 22;20(11-12):1593-602. doi: 10.1016/s0264-410x(01)00486-8. Vaccine. 2002. PMID: 11858867 - Immunity in strain 2 guinea-pigs inoculated with vaccinia virus recombinants expressing varicella-zoster virus glycoproteins I, IV, V or the protein product of the immediate early gene 62.
Lowry PW, Solem S, Watson BN, Koropchak CM, Thackray HM, Kinchington PR, Ruyechan WT, Ling P, Hay J, Arvin AM. Lowry PW, et al. J Gen Virol. 1992 Apr;73 ( Pt 4):811-9. doi: 10.1099/0022-1317-73-4-811. J Gen Virol. 1992. PMID: 1321876 - [Varicella-zoster virus (VZV)].
Kanai K, Yamada S, Inoue N. Kanai K, et al. Uirusu. 2010 Dec;60(2):197-207. doi: 10.2222/jsv.60.197. Uirusu. 2010. PMID: 21488333 Review. Japanese. - VZV T cell-mediated immunity.
Weinberg A, Levin MJ. Weinberg A, et al. Curr Top Microbiol Immunol. 2010;342:341-57. doi: 10.1007/82_2010_31. Curr Top Microbiol Immunol. 2010. PMID: 20473790 Review.
Cited by
- Comparison of quantitations of viral load in varicella and zoster.
Kimura H, Kido S, Ozaki T, Tanaka N, Ito Y, Williams RK, Morishima T. Kimura H, et al. J Clin Microbiol. 2000 Jun;38(6):2447-9. doi: 10.1128/JCM.38.6.2447-2449.2000. J Clin Microbiol. 2000. PMID: 10835029 Free PMC article. - Varicella zoster virus glycoprotein E-specific CD4+ T cells show evidence of recent activation and effector differentiation, consistent with frequent exposure to replicative cycle antigens in healthy immune donors.
Malavige GN, Jones L, Black AP, Ogg GS. Malavige GN, et al. Clin Exp Immunol. 2008 Jun;152(3):522-31. doi: 10.1111/j.1365-2249.2008.03633.x. Epub 2008 Mar 20. Clin Exp Immunol. 2008. PMID: 18363743 Free PMC article. - Evaluation of glycoprotein E subunit and live attenuated varicella-zoster virus vaccines formulated with a single-strand RNA-based adjuvant.
Lee SJ, Park HJ, Ko HL, Lee JE, Lee HJ, Kim H, Nam JH. Lee SJ, et al. Immun Inflamm Dis. 2020 Jun;8(2):216-227. doi: 10.1002/iid3.297. Epub 2020 Mar 13. Immun Inflamm Dis. 2020. PMID: 32167678 Free PMC article. - Varicella-zoster virus glycoproteins B and E are major targets of CD4+ and CD8+ T cells reconstituting during zoster after allogeneic transplantation.
Kleemann P, Distler E, Wagner EM, Thomas S, Klobuch S, Aue S, Schnürer E, Schild H, Theobald M, Plachter B, Tenzer S, Meyer RG, Herr W. Kleemann P, et al. Haematologica. 2012 Jun;97(6):874-82. doi: 10.3324/haematol.2011.052597. Epub 2011 Dec 29. Haematologica. 2012. PMID: 22207687 Free PMC article. - Quantitative analysis of Epstein-Barr virus load by using a real-time PCR assay.
Kimura H, Morita M, Yabuta Y, Kuzushima K, Kato K, Kojima S, Matsuyama T, Morishima T. Kimura H, et al. J Clin Microbiol. 1999 Jan;37(1):132-6. doi: 10.1128/JCM.37.1.132-136.1999. J Clin Microbiol. 1999. PMID: 9854077 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical